Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Nestin helps identify certain melanoma cells in nodular melanoma.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

GnRH treatment can reduce breast cancer cell invasion.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Cantú syndrome is caused by mutations in the ABCC9 gene.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.